Educational resources

20190820 Renal impairment Algorithm_PI update

Non-vitamin K oral anticoagulant options for patients with non-valvular atrial fibrillation and renal impairment

Commissioned by Bayer plc

This NOAC dosing guide has been commissioned by Bayer, who also provided funding for its development. Bayer reviewed and approved the scope and pre-meeting documents, suggested the Chair and experts for the group, and put the dosing guide through full medical approval to ensure its compliance with appropriate regulations.